Marshall L. Michener

1.1k total citations
18 papers, 910 citations indexed

About

Marshall L. Michener is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marshall L. Michener has authored 18 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marshall L. Michener's work include Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Hormonal Regulation and Hypertension (3 papers). Marshall L. Michener is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Hormonal Regulation and Hypertension (3 papers). Marshall L. Michener collaborates with scholars based in United States. Marshall L. Michener's co-authors include Philip Needleman, Clifford B. Saper, David A. Schwartz, Mark G. Currie, S P Adams, David M. Geller, Barbara R. Cole, David G. Standaert, James E. Greenwald and Hatice Tolunay and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Analytical Biochemistry.

In The Last Decade

Marshall L. Michener

18 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marshall L. Michener United States 11 409 394 109 108 105 18 910
Eileen McCall United Kingdom 18 477 1.2× 727 1.8× 182 1.7× 87 0.8× 109 1.0× 30 1.1k
Yoshikazu Morishita Japan 17 284 0.7× 313 0.8× 58 0.5× 94 0.9× 54 0.5× 37 643
Ana V. Villar Spain 18 329 0.8× 699 1.8× 47 0.4× 85 0.8× 72 0.7× 33 1.1k
Alexander V. Vorotnikov Russia 20 217 0.5× 682 1.7× 122 1.1× 83 0.8× 45 0.4× 66 1.2k
Joan Carles Ferreres Spain 20 203 0.5× 786 2.0× 122 1.1× 130 1.2× 174 1.7× 51 1.3k
Robert S. Haworth United Kingdom 27 801 2.0× 1.3k 3.4× 157 1.4× 49 0.5× 99 0.9× 37 1.8k
Julian C. Braz United States 10 581 1.4× 1.0k 2.6× 84 0.8× 32 0.3× 123 1.2× 11 1.3k
Mikio Nakazawa Japan 15 465 1.1× 391 1.0× 62 0.6× 19 0.2× 52 0.5× 89 901
Satoshi Maekawa Japan 21 112 0.3× 582 1.5× 113 1.0× 141 1.3× 92 0.9× 45 1.1k
Teresa Bohlmeyer United States 16 1.0k 2.5× 1.1k 2.7× 87 0.8× 151 1.4× 70 0.7× 18 1.7k

Countries citing papers authored by Marshall L. Michener

Since Specialization
Citations

This map shows the geographic impact of Marshall L. Michener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall L. Michener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall L. Michener more than expected).

Fields of papers citing papers by Marshall L. Michener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall L. Michener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall L. Michener. The network helps show where Marshall L. Michener may publish in the future.

Co-authorship network of co-authors of Marshall L. Michener

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall L. Michener. A scholar is included among the top collaborators of Marshall L. Michener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall L. Michener. Marshall L. Michener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kossen, Karl, Caralee Schaefer, Sharlene Lim, et al.. (2020). IDL-2965: a selective, highly potent, clinical-stage integrin antagonist for treatment of non-alcoholic steatohepatitis. Journal of Hepatology. 73. S450–S450. 2 indexed citations
2.
Kossen, Karl, et al.. (2019). IDL-2965: A Selective, highly-potent, oral Integrin antagonist for IPF. PA5374–PA5374. 7 indexed citations
3.
Eda, Hiroyuki, Jian Zhang, Robert H. Keith, et al.. (2010). Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine. 52(3). 215–220. 65 indexed citations
4.
Meyers, Marvin J., Matthew J. Pelc, Satwik Kamtekar, et al.. (2010). Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode. Bioorganic & Medicinal Chemistry Letters. 20(5). 1543–1547. 31 indexed citations
5.
Levine, Leanna, Marshall L. Michener, Mihaly V. Toth, & Barry C. Holwerda. (1997). Measurement of Specific Protease Activity Utilizing Fluorescence Polarization. Analytical Biochemistry. 247(1). 83–88. 49 indexed citations
6.
Welply, Joseph K., Marshall L. Michener, Susan C. Howard, et al.. (1996). A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1. Proteins Structure Function and Bioinformatics. 26(3). 262–270. 21 indexed citations
7.
Penning, Thomas D., Leslie J. Askonas, Stevan W. Djurić, et al.. (1996). ChemInform Abstract: Kelatorphan and Related Analogues: Potent and Selective Inhibitors of Leukotriene A4 Hydrolase.. ChemInform. 27(9). 3 indexed citations
8.
Gustafson, Mark E., Katrin Junger, Julio Báez, et al.. (1995). Large-Scale Production of HIV-1 Protease from Escherichia coli Using Selective Extraction and Membrane Fractionation. Protein Expression and Purification. 6(4). 512–518. 4 indexed citations
9.
Penning, Thomas D., Leslie J. Askonas, Stevan W. Djurić, et al.. (1995). Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 5(21). 2517–2522. 23 indexed citations
10.
Needleman, Philip, Edward H. Blaine, James E. Greenwald, et al.. (1989). The Biochemical Pharmacology of Atrial Peptides. The Annual Review of Pharmacology and Toxicology. 29(1). 23–54. 153 indexed citations
11.
Greenwald, James E., et al.. (1988). Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat.. Journal of Clinical Investigation. 81(4). 1036–1041. 39 indexed citations
12.
Michener, Marshall L., James K. Gierse, Ramnath Seetharam, et al.. (1986). Proteolytic processing of atriopeptin prohormone.. Molecular Pharmacology. 30(6). 552–557. 59 indexed citations
13.
Michener, Marshall L., et al.. (1986). Phosphorylation of a chromaffin granule-binding protein in stimulated chromaffin cells.. Journal of Biological Chemistry. 261(14). 6548–6555. 46 indexed citations
14.
Needleman, Philip, S P Adams, Barbara R. Cole, et al.. (1985). Atriopeptins as cardiac hormones.. Hypertension. 7(4). 469–482. 341 indexed citations
15.
Michener, Marshall L., M J Peach, & Carl E. Creutz. (1985). Direct Effects of Adrenocorticotropic Hormone on Bovine Adrenomedullary Cells: Adenosine 3′,5′-Monophosphate-Dependent Phosphorylation of Tyrosine Hydroxylase*. Endocrinology. 117(2). 730–737. 8 indexed citations
16.
Murphy, Kenneth M., et al.. (1985). Autoradiographic localization of atriopeptin III receptors in rat kidney. European Journal of Pharmacology. 111(2). 291–292. 41 indexed citations
17.
Michener, Marshall L. & M J Peach. (1984). Failure of β-adrenergic receptors to modulate adrenal medullary secretion. Biochemical Pharmacology. 33(11). 1819–1823. 9 indexed citations
18.
Trachte, George J., Edmund J. Sybertz, Marshall L. Michener, Sue Binder, & M J Peach. (1984). Angiotensin III-induced modulation of neurogenic responses in the rabbit vas deferens and portal vein. Naunyn-Schmiedeberg s Archives of Pharmacology. 326(4). 327–333. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eileen McCall Breakdown of academic impact, for papers by Yoshikazu Morishita Breakdown of academic impact, for papers by Ana V. Villar Breakdown of academic impact, for papers by Alexander V. Vorotnikov Breakdown of academic impact, for papers by Joan Carles Ferreres Breakdown of academic impact, for papers by Robert S. Haworth Breakdown of academic impact, for papers by Julian C. Braz Breakdown of academic impact, for papers by Mikio Nakazawa Breakdown of academic impact, for papers by Satoshi Maekawa Breakdown of academic impact, for papers by Teresa Bohlmeyer
Rankless by CCL
2026